Skip to main content
. Author manuscript; available in PMC: 2020 Jul 20.
Published in final edited form as: Anticancer Drugs. 2017 Jan;28(1):120–126. doi: 10.1097/CAD.0000000000000438

Table 3.

Multivariate analysis of predictors of recurrence at 5 and 10 years.

Parameter Comparison Hazard Ratio 95% Hazard Ratio Confidence Interval P-Value
5 year PFS 10 year PFS 5 Year PFS 10 Year PFS 5 year PFS 10 year PFS
Lymph Node Status Negative vs Positive 9.70 0.23 2.80 33.40 0.84 0.64 <.0001 0.005 Ɨ
Gleason score at biopsy  6–7 vs 8–10 1.80 1.60 1.10 3.10 0.946 2.71 0.030 0.080
PSA density  continuous 6.40 4.09 1.20 10.40 1.645 10.14 0.004 0.002 Ɨ
Tissue VEGF expression  Low vs high 3.50 0.31 1.20 12.00 0.125 0.78 0.023 0.013 Ɨ
Ɨ

Significant at 0.05 level